Melanocortin peptides inhibit urate crystal-induced activation of phagocytic cells

[1]  T. Luger,et al.  Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. , 2008, Endocrine reviews.

[2]  T. Luger,et al.  α-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs , 2007, Annals of the rheumatic diseases.

[3]  A. Catania,et al.  The synthetic melanocortin (CKPV)2 exerts broad anti-inflammatory effects in human neutrophils , 2007, Peptides.

[4]  A. Catania.  The melanocortin system in leukocyte biology , 2007, Journal of leukocyte biology.

[5]  R. Terkeltaub,et al.  Engagement of CD14 Mediates the Inflammatory Potential of Monosodium Urate Crystals1 , 2006, The Journal of Immunology.

[6]  P. Grieco,et al.  Melanocortin 3 receptors control crystal‐induced inflammation , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  S. Akira,et al.  MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. , 2006, The Journal of clinical investigation.

[8]  S. Getting,et al.  Targeting melanocortin receptors as potential novel therapeutics. , 2006, Pharmacology & therapeutics.

[9]  G. Paré,et al.  Characterization of an activation factor released from human neutrophils after stimulation by triclinic monosodium urate crystals. , 2006, The Journal of rheumatology.

[10]  J. M. Lipton,et al.  Inhibitory effects of the peptide (CKPV)2 on endotoxin-induced host reactions. , 2006, The Journal of surgical research.

[11]  F. Martinon,et al.  Gout-associated uric acid crystals activate the NALP3 inflammasome , 2006, Nature.

[12]  S. Manna,et al.  α‐melanocyte‐stimulating hormone down‐regulates CXC receptors through activation of neutrophil elastase , 2006, European Journal of Immunology.

[13]  H. Kondo,et al.  Induction of triggering receptor expressed on myeloid cells 1 in murine resident peritoneal macrophages by monosodium urate monohydrate crystals. , 2006, Arthritis and rheumatism.

[14]  M. Yüksel,et al.  The role of cyclooxygenase inhibition in the effect of alpha-melanocyte-stimulating hormone on reactive oxygen species production by rat peritoneal neutrophils. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.

[15]  S. Manna,et al.  α‐Melanocyte‐stimulating hormone inhibits lipopolysaccharide‐induced biological responses by downregulating CD14 from macrophages , 2003, FEBS letters.

[16]  O. Florey,et al.  Safe disposal of inflammatory monosodium urate monohydrate crystals by differentiated macrophages. , 2002, Arthritis and rheumatism.

[17]  H. Christian,et al.  Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. , 2002, Arthritis and rheumatism.

[18]  A. Matsukawa,et al.  Analysis of the cytokine network among tumor necrosis factor alpha, interleukin-1beta, interleukin-8, and interleukin-1 receptor antagonist in monosodium urate crystal-induced rabbit arthritis. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[19]  J. M. Lipton,et al.  The neuropeptide α-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro , 1996, Peptides.

[20]  V. Hruby,et al.  Truncation studies of α-melanotropin peptides identify tripeptide analogues exhibiting prolonged agonist bioactivity , 1996, Peptides.

[21]  S. McColl,et al.  Inflammatory microcrystals differentially regulate the secretion of macrophage inflammatory protein 1 and interleukin 8 by human neutrophils: a possible mechanism of neutrophil recruitment to sites of inflammation in synovitis , 1995, The Journal of experimental medicine.

[22]  S. Ferreira,et al.  Peripheral analgesic activities of peptides related to α‐melanocyte stimulating hormone and interleukin‐1β193–195 , 1992 .

[23]  M. Perretti,et al.  α-melanocyte-stimulating hormone reduces interleukin-lβ effects on rat stomach preparations possibly through interference with a type I receptor , 1991 .

[24]  G. Weissmann,et al.  Formation of leukotrienes and hydroxy acids by human neutrophils and platelets exposed to monosodium urate. , 1984, Prostaglandins.

[25]  A. Bøyum,et al.  Isolation of human blood monocytes with Nycodenz, a new non-ionic iodinated gradient medium. , 1983, Scandinavian journal of immunology.

[26]  S. Boyden.  THE CHEMOTACTIC EFFECT OF MIXTURES OF ANTIBODY AND ANTIGEN ON POLYMORPHONUCLEAR LEUCOCYTES , 1962, The Journal of experimental medicine.

[27]  E. Healy,et al.  α-Melanocyte-Stimulating Hormone Suppresses Antigen-Induced Lymphocyte Proliferation in Humans Independently of Melanocortin 1 Receptor Gene Status1 , 2005, The Journal of Immunology.

[28]  S. Poole,et al.  Peripheral analgesic activities of peptides related to alpha-melanocyte stimulating hormone and interleukin-1 beta 193-195. , 1992, British journal of pharmacology.

[29]  M. Perretti,et al.  Alpha-melanocyte-stimulating hormone reduces interleukin-1 beta effects on rat stomach preparations possibly through interference with a type I receptor. , 1991, European journal of pharmacology.

[30]  I. Spilberg,et al.  Crystal-induced chemotactic factor. , 1988, Methods in Enzymology.

[31]  I. Spilberg,et al.  [18] Crystal-induced chemotactic factor , 1988 .

[32]  A. Bøyum,et al.  Isolation of mononuclear cells and granulocytes from human blood. , 1968 .

[33]  A. Böyum,et al.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. , 1968, Scandinavian journal of clinical and laboratory investigation. Supplementum.